Novartis
DC · 31 filings, 2025
What the money shows
Novartis reported $7.8M in federal lobbying for 2025 across 31 filings. The filings name 8 lobbying firms, led by Novartis and Corcoran & Associates Inc. DBA Corcoran Partners. The matched PAC file shows $48,000 to 0 lawmakers. The filing text lists 9 issue areas.
Sources: Senate LDA · FEC
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Medicare/Medicaid · Trade (domestic/foreign) · Taxation/Internal Revenue Code · Budget/Appropriations · Copyright/Patent/Trademark · Labor Issues/Antitrust/Workplace · Pharmacy · Medical/Disease Research/Clinical Labs
2Through these firms · 8
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5224A bill to improve training for airport drivers in the movement area at commercial service airports through…